PMID: 24355990
rstakten fortstter att ka fr och ligger nu p +9% fr bostadsrtter och +6% fr villor
Of importance, experimental studies have suggested that several GLP-1 RAs can cross the bloodbrain barrier, at least at some extent, upon systemic administration [46,47]
Contrary to Defendants assertions, they are not entitled to a blanket ruling on preemption that the warnings in their GLP-1RA labels were adequate, and Plaintiffs claims do not arise merely from nausea, vomiting, or constipation
When to speak to your GP or oncologist Contact your GP, prescriber, or oncology team if you experience: Any new lumps, changes in the affected or unaffected breast, or new symptoms that prompt concern about recurrence Persistent nausea or vomiting that stops you from keeping fluids down Rapid or significant weight loss beyond whats expected Signs of dehydration (dark urine, dizziness, reduced urination) New fatigue that feels different from your post-treatment fatigue Worsening joint pain or new bone pain Increasing anxiety, low mood, or fear of recurrence thats affecting daily life Any difficulty attending cancer follow-up appointments because of side effects Dont delay routine cancer surveillance because of Wegovy
Most of the reported side effects are similar to semaglutide, with the majority of them being GI related
